| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.12B | +20.1% |
| Gross profit | ¥0.03B | — |
| Operating income | ¥-0.01B | — |
| Net income | ¥-0.01B | — |
| Gross margin | 26.9% | Net margin -10.0% |
| Revenue Q/Q | -49.7% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.09B | 73.1% |
| R&D | ¥0.01B | 9.3% |
| SG&A | ¥0.03B | 21.3% |
| Tax & other | ¥-0.00B | -0.1% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
欧普康视 ・ 利安隆 ・ 吉大通信 ・ 诚迈科技 ・ 雄塑科技 ・ 国瑞科技 ・ 康泰生物 ・ 飞荣达 ・ 立昂技术 ・ 长川科技 ・ 恒锋信息 ・ 金太阳
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies